A cross-sectional approach to identification & interrogation of adaptive & functional mutations affecting CCHFV replication & pathogenicity in humans

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:2 publications

Grant number: MR/T029196/1

Grant search

Key facts

  • Disease

    Crimean-Congo haemorrhagic fever
  • Start & end year

    2020
    2024
  • Known Financial Commitments (USD)

    $102,498.75
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Dr. David Allen
  • Research Location

    United Kingdom
  • Lead Research Institution

    London Sch of Hygiene & Tropic. Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Identification of CCHFV amino acid mutations: determine unique genetic variation in human, tick & other mammal-isolated CCHFV genome sequences -Analysis of publicly available sequences from in NCBI/EMBL/DDBJ database, identify genetic variation associated with host via bioinformatics technique and virus evolutionary analysis -Map mutations onto known structures of CCHFV proteins to predict structural and biophysical impact of amino acid substitutions on function of viral proteins by computational analysis Tracking the emergence of mutations in CCHFV human cases: examine sequence variants of CCHFV isolates from patients: -CCHFV sequencing in human patients & ticks collected in Turkey using a novel sequencing method (Oxford Nanopore MinION) -Examine genetic variations of CCHFV for intra-host single nucleotide variants (iSNVs) -Combining genetic data of CCHFV isolates with clinical outcomes of cases (fatal vs recovered), highlight genetic determinants of viral pathogenicity Experimental evaluation of identified mutations: Examine functional changes of mutations found in in silico and in vivo work -Create a library of plasmids expressing CCHFV proteins with particular single/multiple amino acid mutations predicted to induce functional changes -Establish viral entry assay using infectious particles/psuedotyped VSV bearing CCHFV envelope in a CCHFV-susceptible human cell line, evaluate infectivity via viral glycoprotein Gn/Gc with host-specific mutations & neutralizing antibody escape mutations -Develop Hazara virus infectious virus particle system into a CCHFV infectious clone to evaluate virus entry & neutralizing antibody escape mutations -Establish CCHFV minigenome in a human cell line to evaluate virus genome replication and transcription -Examine virus replication kinetics in human, non-human primate, and tick cell lines, determine virus sequences of each passage by NGS to examine emergence of genetic variations depending on the host cell species

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Development of targeted whole genome sequencing approaches for Crimean-Congo haemorrhagic fever virus (CCHFV).

Phylogenetic Characterization of Crimean-Congo Hemorrhagic Fever Virus Detected in African Blue Ticks Feeding on Cattle in a Ugandan Abattoir.